MCID: RNL011
MIFTS: 47

Renal Osteodystrophy malady

Categories: Rare diseases, Nephrological diseases, Bone diseases

Aliases & Classifications for Renal Osteodystrophy

About this section

Aliases & Descriptions for Renal Osteodystrophy:

Name: Renal Osteodystrophy 11 49 13 67
Renal Rickets 11 47 67
 
Chronic Kidney Disease-Mineral and Bone Disorder 38

Classifications:



External Ids:

Disease Ontology11 DOID:13068
ICD1029 N25.0
ICD9CM31 588.0
MeSH38 D012080
NCIt44 C114827

Summaries for Renal Osteodystrophy

About this section
Wikipedia:70 Renal osteodystrophy is currently defined as an alteration of bone morphology in patients with chronic... more...

MalaCards based summary: Renal Osteodystrophy, also known as renal rickets, is related to cranial nerve palsy and end stage renal failure, and has symptoms including uraemia odour and uraemia odour. An important gene associated with Renal Osteodystrophy is PTH (Parathyroid Hormone), and among its related pathways are FGF signaling pathway and Vitamin D synthesis. Affiliated tissues include bone, kidney and liver, and related mouse phenotypes are endocrine/exocrine gland and growth/size/body region.

Related Diseases for Renal Osteodystrophy

About this section

Diseases related to Renal Osteodystrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 100)
idRelated DiseaseScoreTop Affiliating Genes
1cranial nerve palsy30.2BGLAP, PTH
2end stage renal failure11.2
3chronic kidney failure11.2
4achondrogenesis10.5BGLAP, PTH
5testicular brenner tumor10.4CASR, PTH
6hypercalciuria, absorptive10.4CASR, VDR
7obesity, severe bmiq910.4BGLAP, PTH
8cystic echinococcosis10.4FGF23, PTH
9opthalmomandibulomelic dysplasia10.4PTH, VDR
10cervix disease10.4PTH, VDR
11onychotrichodysplasia and neutropenia10.3FGF23, PTH
12testicular microlithiasis10.3FGF23, PTH
13hypochondrogenesis10.3CALCA, PTH
14echolalia10.3BGLAP, PTH
15nodular goiter10.3BGLAP, CALCA
16impotence10.3CALCA, PTH
17hyperparathyroidism10.3
18peritonitis10.3
19silver-russell syndrome due to 7p11.2p13 microduplication10.3BGLAP, CASR, VDR
20retinal vasculitis10.3CASR, TNFRSF11B
21polyradiculopathy10.3CALCA, PTH
22bone resorption disease10.2BGLAP, TNFRSF11B
23mixed cell type adenoma of parathyroid10.2BGLAP, CASR, PTH
24scrotal carcinoma10.2BGLAP, CALCA
25weaver syndrome 110.2BGLAP, PTH, VDR
26anal buschke-lowenstein tumor10.2CALCA, PTH
27tibial hemimelia10.2CALCA, TNFRSF11B
28gestational diabetes10.2BGLAP, FGF23, PTH
29periodic paralyses10.2CALCA, FGF23
30commensal bacterial infectious disease10.2BGLAP, FGF23, PTH
31t cell deficiency10.1CASR, FGF23, PTH
32acute salpingo-oophoritis10.1BGLAP, CALCA
33substance dependence10.1FGF23, PTH, VDR
34vulvovaginitis10.1BGLAP, TNFRSF11B
35ovarian insufficiency, familial10.1BGLAP, PTH, TNFRSF11B
36dengue hemorrhagic fever10.1CALCA, VDR
37loeys-dietz syndrome10.1FGF23, PTH, VDR
38parathyroid transitional clear cell adenoma10.1BGLAP, CALCA, PTH
39dyscalculia10.1BGLAP, CALCA, PTH
40protein-losing enteropathy10.1FGF23, PTH, VDR
41anaerobic meningitis10.1CALCA, TNFRSF11B
42atrial standstill10.1BGLAP, TNFRSF11B, VDR
43tuberous sclerosis-110.1FGF23, PTH
44central nervous system hemangioma10.1CALCA, PTH
45parathyroid carcinoma10.0CALCA, CASR, PTH
46neisseria meningitidis infection10.0IGFBP5, VDR
47osteomalacia10.0
48cervicitis10.0
49uremia10.0
50toenail dystrophy, isolated10.0CALCA, FGF23, PTH

Comorbidity relations with Renal Osteodystrophy via Phenotypic Disease Network (PDN):


Deficiency AnemiaAcute Kidney Failure
Chronic Kidney FailureIschemic Heart Disease
Heart DiseaseProtein-Energy Malnutrition
Acute Cystitis

Graphical network of the top 20 diseases related to Renal Osteodystrophy:



Diseases related to renal osteodystrophy

Symptoms for Renal Osteodystrophy

About this section

UMLS symptoms related to Renal Osteodystrophy:


uraemia odour

Drugs & Therapeutics for Renal Osteodystrophy

About this section

Drugs for Renal Osteodystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 60)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SevelamerapprovedPhase 4, Phase 27452757-95-6, 152751-57-03085017
Synonyms:
Sevelamer
 
Sevelamero
Sevelamerum
Sévélamer
2
Zoledronic acidapprovedPhase 4290118072-93-868740
Synonyms:
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate
(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
118072-93-8
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
AC-1092
AC1L2ACJ
AC1Q6RN3
AKOS005145739
Aclasta
Anhydrous Zoledronic Acid
BIDD:GT0292
BIDD:PXR0134
Bio-0112
Bisphosphonate 3
C088658
CGP 42'446
CGP 42446
CGP 42446A
CGP-42'446
CGP-42446
CHEBI:46557
CHEMBL924
CID68740
D08689
DB00399
 
FT-0082657
HMS2089O09
I06-0710
KS-1132
LS-181815
MolPort-002-885-874
MolPort-003-850-890
NCGC00159521-02
NCGC00159521-03
NSC721517
Novartis brand of zoledronic acid
Reclast
Reclast (TN)
S00092
S1314_Selleck
UNII-70HZ18PH24
ZOL
Zol
Zoledronate
Zoledronic Acid Anhydrous
Zoledronic Acid, Anhydrous
Zoledronic acid
Zoledronic acid (INN)
Zoledronic acid [USAN:INN]
Zometa
Zometa (Novartis)
Zometa (TN)
Zometa Concentrate
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
3
PamidronateapprovedPhase 44440391-99-94674
Synonyms:
(3-AMINO-1-HYDROXY-1-PHOSPHONO-PROPYL)PHOSPHONIC ACID
(3-Amino-1-hydroxypropylidene)bisphosphonic acid
(3-Amino-1-hydroxypropylidene)diphosphonic acid
(3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
(3-amino-1-hydroxypropane-1,1-diyl)bis(phosphonic acid)
(3-amino-1-hydroxypropylidene)-1,1-biphosphonate
(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate
1-hydroxy-3-aminopropane-1,1-diphosphonic acid
3-Amino-1-hydroxypropylidene-1,1-diphosphonate
40391-99-9
57248-88-1
57248-88-1 (di-hydrochloride salt)
AC1L1IP4
AHPrBP
AKOS003599275
APD
Acide pamidronique
Acide pamidronique [INN-French]
Acido pamidronico
Acido pamidronico [INN-Spanish]
Acidum pamidronicum
Acidum pamidronicum [INN-Latin]
Amidronate
Aminomux
Aredia
BIDD:GT0538
Bisphosphonate 6
C019248
C07395
C3H11NO7P2
 
CHEMBL834
CID4674
ChemDiv1_025240
D07281
DB00282
EINECS 254-905-2
HMS2090C13
HMS658L06
HSCI1_000312
I14-2407
LS-174826
MolPort-002-131-054
NCGC00159433-02
NCGC00159433-03
Novartis brand of pamidronate disodium salt
PAMIDRONATE DISODIUM
PAMIDRONIC ACID
Pamidronate Disodium
Pamidronic acid
Pamidronic acid (INN)
Pamidronic acid [INN:BAN]
Ribodroat
Ribodroat (TN)
STOCK1N-12562
UNII-OYY3447OMC
amino-1-hydroxypropane-1,1-diphosphonate
aminohydroxypropylidene diphosphonate
aminopropanehydroxydiphosphonate
pamidronate
pamidronate calcium
pamidronate monosodium
4
Ergocalciferolapproved, nutraceuticalPhase 4, Phase 3, Phase 2123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
5vitamin dPhase 4, Phase 3, Phase 21653
6VitaminsPhase 4, Phase 3, Phase 2, Phase 15095
7Bone Density Conservation AgentsPhase 4, Phase 3, Phase 23266
8Trace ElementsPhase 4, Phase 3, Phase 2, Phase 15802
91 alpha-hydroxyergocalciferolPhase 4, Phase 225
10ErgocalciferolsPhase 4, Phase 3, Phase 21232
11MicronutrientsPhase 4, Phase 3, Phase 2, Phase 15802
12Liver ExtractsPhase 43868
13DiphosphonatesPhase 4446
14Ibandronic acidPhase 480
15Vitamin D2NutraceuticalPhase 4, Phase 3, Phase 21232
16CalciferolNutraceuticalPhase 4, Phase 3, Phase 21334
17
Magnesium hydroxideapprovedPhase 2, Phase 3381309-42-8
Synonyms:
 
Magnesium dihydroxide
Milk of magnesia
18
Cholecalciferolapproved, nutraceuticalPhase 3, Phase 285167-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
19Pharmaceutical SolutionsPhase 37793
20HydroxycholecalciferolsPhase 3102
21Calcium, DietaryPhase 3, Phase 25525
22CalcifediolPhase 34219356-17-3
23VaccinesPhase 3, Phase 26428
24Calcimimetic AgentsPhase 3, Phase 269
25HormonesPhase 3, Phase 213979
26Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 212767
27Cinacalcet HydrochloridePhase 3, Phase 269
28Hormone AntagonistsPhase 3, Phase 212778
29
Calcium carbonateapprovedPhase 2208471-34-1
Synonyms:
CaCO3
Calcium carbonate
Calcium carbonate (1:1)
Calciumcarbonat
Carbonate de calcium
 
Carbonato de calcio
Carbonic acid calcium salt (1:1)
E 170
Kalziumkarbonat
Kohlensaurer kalk
Precipitated calcium carbonate
30
Folic Acidapproved, nutraceutical, vet_approvedPhase 1, Phase 2427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
31
Nicotinamideapproved, NutraceuticalPhase 1, Phase 290298-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3 amide
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
32
Niacinapproved, investigational, nutraceuticalPhase 1, Phase 290659-67-6938
Synonyms:
3-Carboxylpyridine
3-Carboxypyridine
3-Pyridinecarboxylate
3-Pyridinecarboxylic acid
3-Pyridylcarboxylate
3-Pyridylcarboxylic acid
3-carboxypyridine
Acide Nicotinique
Acido nicotinico
Acidum Nicotinicum
Akotin
Anti-pellagra vitamin
Apelagrin
Daskil
Efacin
Enduracin
Linic
M-Pyridinecarboxylic Acid
Niac
Niacin
Niacine
Niacor
Nicacid
Nicamin
Nicangin
 
Nico-Span
Nicobid
Nicocap
Nicodelmine
Nicolar
Niconacid
Nicosan 3
Nicotinate
Nicotinic Acid
Nicotinic acid
Nicotinipca
Nicyl
Nikotinsaeure
Nyclin
P.P. factor
PP Factor
Pellagra preventive factor
Pellagrin
Pelonin
Pyridine-beta-carboxylic acid
Slo-niacin
Vitamin B3
Wampocap
beta-Pyridinecarboxylic acid
pyridine-β-carboxylic acid
β-pyridinecarboxylic acid
33
Calcitriolapproved, nutraceuticalPhase 220132222-06-3134070, 5280453
Synonyms:
(1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol
(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha,25-Dihydroxyvitamin D3
1,25 (OH)2 D3
1,25 Dihydroxycholecalciferol
1,25(OH)2-20epi-D3
1,25(OH)2D3 & CD4
1,25(OH2)D3
1,25-(OH)2-D3
1,25-(OH)2D3
1,25-DHCC
1,25-DIHYDROXYCHOLECALCIFEROL
1,25-Dihydroxycholecalciferol
1,25-Dihydroxycholecaliferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1,25-dihydroxy vitamin D3
1,25-dihydroxy-20-epi-Vitamin D3
1,25-dihydroxycholecalciferol
1,25D3
1-alpha,-1,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxycholecalciferol
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1-alpha-25-dihydroxyvitamin D3
1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3
17936_FLUKA
17936_SIGMA
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1alpha,25(OH)2-D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D
1alpha,25-Dihydroxyvitamin D3
1db1
1α,25(OH)2D3
1α,25-dihydroxycholecalciferol
1α,25-dihydroxyvitamin D3
20-epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
32222-06-3
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4
9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol
AC-1859
AC1NQX1S
 
Ambap32222-06-3
Asentar
BCBcMAP01_000160
BML2-E03
BSPBio_001287
C01673
CCRIS 5522
CD-2027
CHEBI:17823
CHEMBL846
CID5280453
CPD000466393
Calcijex
Calcijex, Silkis, Rocaltrol, Topitriol, Cholecalciferol,Calcitriol
Calcitriol
Calcitriol (JAN/USAN/INN)
Calcitriol [USAN:INN:BAN:JAN]
Calcitriolum
Calcitriolum [INN-Latin]
D00129
D1530_SIGMA
DN 101
DN-101
Decostriol
Dihydroxyvitamin D3
EINECS 250-963-8
HMS1361A09
HMS1791A09
HMS1989A09
HMS2051F06
HMS2089N03
HSDB 3482
IDI1_033757
LMST03020258
LS-53093
MC-1288
MC1288
MLS000759536
MLS001424122
MolPort-002-045-698
NCGC00161327-01
NCGC00161327-04
Ro 21-5535
Ro 215535
Ro-21-5535
Rocaltrol
Rocaltrol (TN)
S1466_Selleck
SAM001246772
SMR000466393
Silkis
Soltriol
Spectrum5_002061
Topitriol
Toptriol
U 49562
Vectical
ZINC03924790
calcitriol
vit D
34Hypolipidemic AgentsPhase 1, Phase 22721
35Vitamin B ComplexPhase 1, Phase 24229
36Lipid Regulating AgentsPhase 1, Phase 22702
37AntimetabolitesPhase 1, Phase 211774
38Vasodilator AgentsPhase 1, Phase 23438
39Nicotinic AcidsPhase 1, Phase 2906
40Anti-Ulcer AgentsPhase 21767
41DihydroxycholecalciferolsPhase 232
42Chelating AgentsPhase 21365
43Insulin, Globin ZincPhase 24523
44Gastrointestinal AgentsPhase 28109
45AntacidsPhase 21767
46insulinPhase 24524
47Hypoglycemic AgentsPhase 25733
48Vasoconstrictor AgentsPhase 22027
49PhytosterolNutraceuticalPhase 2115
50Vitamin B9NutraceuticalPhase 1, Phase 24279

Interventional clinical trials:

(show all 39)
idNameStatusNCT IDPhase
1How Bone is Made in Children Receiving DialysisUnknown statusNCT01799317Phase 4
2Osteopenia and Renal Osteodystrophy: Evaluation and ManagementCompletedNCT00108394Phase 4
3Zoledronic Acid to Prevent Bone Loss After Kidney TransplantationCompletedNCT01675089Phase 4
4The Prevalence of Osteoporosis in Hemodialysis PatientsCompletedNCT00308828Phase 4
5Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate SupplementationCompletedNCT02249741Phase 4
6Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant RecipientsUnknown statusNCT00752401Phase 3
7Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) VaccinationCompletedNCT00964210Phase 3
8Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 3
9Impact of a Multidisciplinary Intensive Management Clinic on Outcomes in Multi-Ethnic Asian Incident Hemodialysis PatientsRecruitingNCT01509690Phase 2, Phase 3
10Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney DiseaseRecruitingNCT02542319Phase 2, Phase 3
11Kidney Yin/Yang Replenishment on Patients With Renal OsteodystrophyUnknown statusNCT01665651Phase 2
1212-month Study of AMG 073 in Renal OsteodystrophyCompletedNCT00527085Phase 2
13Regulation of Bone Formation in Renal OsteodystrophyCompletedNCT00560300Phase 2
14Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance DialysisCompletedNCT00004340Phase 2
15Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis PatientsCompletedNCT00660530Phase 2
16Vitamin D, Insulin Resistance and Inflammation in ESRDCompletedNCT00656032Phase 2
17The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis PatientsCompletedNCT00508885Phase 1, Phase 2
18Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum CarbonateCompletedNCT00458289Phase 1
19The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis PatientsCompletedNCT00316472Phase 1
20Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis PatientsUnknown statusNCT01382966
21The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood PressureUnknown statusNCT00452049
22Renal Osteodystrophy: A Fresh ApproachCompletedNCT00859612
23Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRDCompletedNCT00364234
24Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT00285467
25Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis PatientsCompletedNCT00412139
26Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.CompletedNCT00266708
27A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant RecipientsCompletedNCT01163669
28A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary HyperparathyroidismCompletedNCT01149291
29Early-onset Obesity and Cognitive Impairment in Children With PseudohypoparathyroidismCompletedNCT02411461
30Renal Osteodystrophy: An Individual Management ApproachRecruitingNCT02440581
31Clinical Observation on Bone Metabolism Induced by Chronic Renal InsufficiencyRecruitingNCT02147782
32Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)RecruitingNCT02556216
33Bone Microarchitecture in the Transplant PatientRecruitingNCT02729142
34Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal TransplantationRecruitingNCT02523209
35Chronic Kidney Disease and Bone - Correlation Between 18F-PET-TT Imaging and Histomorphometry of Bone in CKD PatientsRecruitingNCT02967042
36Resistance to Vitamin D or Parathyroid HormoneRecruitingNCT00001242
37Effectiveness of Probiotics to Treat End Stage Renal DiseaseNot yet recruitingNCT02929225
38Klotho Gene Polymorphism in Dialyzed Patients With HyperphosphatemiaTerminatedNCT00374712
39Treatment of Secondary Hyperparathyroidism in the Uremic PatientTerminatedNCT00469599

Search NIH Clinical Center for Renal Osteodystrophy


Cochrane evidence based reviews: chronic kidney disease-mineral and bone disorder

Genetic Tests for Renal Osteodystrophy

About this section

Anatomical Context for Renal Osteodystrophy

About this section

MalaCards organs/tissues related to Renal Osteodystrophy:

35
Bone, Kidney, Liver, Endothelial, Bone marrow, Testes, Spinal cord

Animal Models for Renal Osteodystrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Renal Osteodystrophy:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053798.3CASR, FGF23, IGFBP4, IGFBP5, PTH, VDR
2MP:00053787.1CASR, FGF23, IGFBP4, IGFBP5, PTH, TNFRSF11B

Publications for Renal Osteodystrophy

About this section

Articles related to Renal Osteodystrophy:

(show top 50)    (show all 531)
idTitleAuthorsYear
1
Correction: Bone Canopies in Pediatric Renal Osteodystrophy. (27167735)
2016
2
A rare manifestation of renal osteodystrophy in a non-compliant child on hemodialysis: Answers. (25966786)
2015
3
The importance of bone biomarkers in the diagnosis of renal osteodystrophy. (21291118)
2010
4
Infrared spectroscopy indicates altered bone turnover and remodeling activity in renal osteodystrophy. (20200925)
2010
5
The influence of medical and nonmedical factors to the progression of renal osteodystrophy. (20102101)
2009
6
Chronic pachymeningitis and bilateral facial paralysis secondary to renal osteodystrophy. (18347262)
2008
7
Clinical and economic burden of fractures in patients with renal osteodystrophy. (17474555)
2007
8
Renal osteodystrophy, phosphate homeostasis, and vascular calcification. (17635820)
2007
9
Cranial nerve palsies in renal osteodystrophy. (17162202)
2007
10
Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients. (15665550)
2005
11
Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. (15730056)
2005
12
Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease. (15882311)
2005
13
Radiologic features of renal osteodystrophy in a patient with "normal" bone mineralization. (12970649)
2003
14
Renal osteodystrophy. (12041521)
2002
15
Pathophysiology of renal osteodystrophy. (10912533)
2000
16
The role of imaging techniques in the study of renal osteodystrophy. (10981482)
2000
17
Diagnosis and monitoring of renal osteodystrophy. (11128431)
2000
18
High frequency of iron bone deposits in a Mexican population with renal osteodystrophy. (9568820)
1998
19
Surgical correction of angular deformity of the knee in children with renal osteodystrophy. (8989700)
1997
20
Myelofibrosis secondary to renal osteodystrophy. (8730443)
1996
21
Renal osteodystrophy. (7704782)
1994
22
The role of bone biopsy in the management of patients with renal osteodystrophy. (8011971)
1994
23
Renal osteodystrophy in diabetic patients. (8355457)
1993
24
Renal osteodystrophy and hypercalcemia. (8512774)
1993
25
Maxillary brown tumor as manifestation of renal osteodystrophy. (8341400)
1993
26
Pattern of renal osteodystrophy in haemodialysis patients in Saudi Arabia. (8396743)
1993
27
Reevaluation of the usefulness of serum free hydroxyproline as a parameter for assessing renal osteodystrophy. (8336400)
1993
28
Recent advances in the management of renal osteodystrophy in children. (7859020)
1993
29
PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. (1300330)
1992
30
Renal osteodystrophy, disorders of vitamin D metabolism, and hypophosphatasia. (1599820)
1992
31
The radiographic spectrum of renal osteodystrophy. (1986484)
1991
32
Prevention of renal osteodystrophy. (1813786)
1991
33
Diagnostic evaluation of plasma free gamma-carboxyglutamic acid in maintenance hemodialytic patients with renal osteodystrophy]. (2082053)
1990
34
Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis. (2088463)
1990
35
Renal osteodystrophy: some new questions on an old disorder. (3285668)
1988
36
Histological manifestations of abnormal parathyroid hormone metabolism in renal osteodystrophy. (3180817)
1988
37
Influence of keto acid (KA) treatment on renal osteodystrophy. (3501767)
1987
38
Thallium-201 and technetium-99m subtraction scanning of the parathyroid glands in patients with hyperparathyroidism due to renal osteodystrophy. (3038464)
1987
39
Behavior of the vitamin D endocrine system in the development of renal osteodystrophy. (3299575)
1986
40
Renal osteodystrophy in asymptomatic hemodialysis patients: evidence of a sex-dependent distribution and predictive value of serum aluminum measurements. (3812472)
1986
41
Roentgenographic manifestations of maxillomandibular renal osteodystrophy. (4058622)
1985
42
Bone aluminum deposition in renal osteodystrophy. (6185842)
1983
43
Linear decline in serum alkaline phosphatase activity during treatment of renal osteodystrophy. (6401474)
1983
44
Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. (6834691)
1983
45
1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. (6687749)
1983
46
Therapeutic effects of 25-hydroxycholecalciferol and sodium etidronate on renal osteodystrophy. (6820473)
1982
47
Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication. (6982452)
1982
48
Radiographic interpretation of the mandibular angular cortex: a diagnostic tool in metabolic bone loss. Part II. Renal osteodystrophy. (6954448)
1982
49
Pattern of renal osteodystrophy amongst north Indian patients. (7185821)
1982
50
Patellofemoral abnormalities in renal osteodystrophy. (7079493)
1982

Variations for Renal Osteodystrophy

About this section

Expression for genes affiliated with Renal Osteodystrophy

About this section
Search GEO for disease gene expression data for Renal Osteodystrophy.

Pathways for genes affiliated with Renal Osteodystrophy

About this section

GO Terms for genes affiliated with Renal Osteodystrophy

About this section

Cellular components related to Renal Osteodystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00056157.5BGLAP, CALCA, FGF23, IGFBP1, IGFBP4, PTH
2extracellular regionGO:00055766.3BGLAP, CALCA, FGF23, IGFBP1, IGFBP4, IGFBP5

Biological processes related to Renal Osteodystrophy according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1cellular response to vitamin DGO:007130510.4BGLAP, FGF23
2response to vitamin DGO:003328010.3BGLAP, PTH
3response to inorganic substanceGO:001003510.3BGLAP, TNFRSF11B
4positive regulation of ossificationGO:004577810.3CALCA, PTH
5regulation of bone mineralizationGO:003050010.3BGLAP, FGF23
6response to magnesium ionGO:003202610.2FGF23, TNFRSF11B
7positive regulation of vitamin D 24-hydroxylase activityGO:001098010.2FGF23, VDR
8regulation of insulin-like growth factor receptor signaling pathwayGO:004356710.1IGFBP1, IGFBP4
9negative regulation of bone resorptionGO:004577910.0CALCA, TNFRSF11B
10negative regulation of osteoblast differentiationGO:00456689.9FGF23, IGFBP5
11type B pancreatic cell proliferationGO:00443429.7IGFBP4, IGFBP5
12regulation of glucose metabolic processGO:00109069.7IGFBP4, IGFBP5
13adenylate cyclase-activating G-protein coupled receptor signaling pathwayGO:00071899.7CALCA, PTH
14positive regulation of insulin-like growth factor receptor signaling pathwayGO:00435689.6IGFBP4, IGFBP5
15skeletal system developmentGO:00015018.8BGLAP, IGFBP4, PTH, TNFRSF11B, VDR
16cellular calcium ion homeostasisGO:00068748.5CALCA, CASR, PTH, VDR
17agingGO:00075688.5BGLAP, CALCA, IGFBP1, IGFBP5
18cellular protein metabolic processGO:00442678.4CALCA, IGFBP1, IGFBP4, IGFBP5
19signal transductionGO:00071657.7IGFBP1, IGFBP4, IGFBP5, TNFRSF11B, VDR

Molecular functions related to Renal Osteodystrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1insulin-like growth factor II bindingGO:00319958.8IGFBP1, IGFBP4, IGFBP5
2insulin-like growth factor I bindingGO:00319948.7IGFBP1, IGFBP4, IGFBP5
3insulin-like growth factor bindingGO:00055208.5IGFBP1, IGFBP4, IGFBP5

Sources for Renal Osteodystrophy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet